BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horimasu Y, Ohshimo S, Bonella F, Tanaka S, Ishikawa N, Hattori N, Kohno N, Guzman J, Costabel U. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis. Respirology 2015;20:439-44. [PMID: 25581455 DOI: 10.1111/resp.12466] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 10.1] [Reference Citation Analysis]
Number Citing Articles
1 Mota PC, Soares ML, Vasconcelos CD, Ferreira AC, Lima BA, Manduchi E, Moore JH, Melo N, Novais-bastos H, Pereira JM, Guimarães S, Moura CS, Marques JA, Morais A. Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival. J Mol Med. [DOI: 10.1007/s00109-022-02242-y] [Reference Citation Analysis]
2 Peng Y, Wang ZN, Xu AR, Fang ZF, Chen SY, Hou XT, Zhou ZQ, Lin HM, Xie JX, Tang XX, Wang DY, Zhong NS. Mucus Hypersecretion and Ciliary Impairment in Conducting Airway Contribute to Alveolar Mucus Plugging in Idiopathic Pulmonary Fibrosis. Front Cell Dev Biol 2021;9:810842. [PMID: 35174169 DOI: 10.3389/fcell.2021.810842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wu X, Li W, Luo Z, Chen Y. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis. Sci Rep 2021;11:24007. [PMID: 34907291 DOI: 10.1038/s41598-021-03533-z] [Reference Citation Analysis]
4 Michalski JE, Kurche JS, Schwartz DA. From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic? Transl Res 2021:S1931-5244(21)00243-7. [PMID: 34547499 DOI: 10.1016/j.trsl.2021.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
5 Isshiki T, Koyama K, Homma S, Sakamoto S, Yamasaki A, Shimizu H, Miyoshi S, Nakamura Y, Kishi K. Association of rs3750920 polymorphism in TOLLIP with clinical characteristics of fibrosing interstitial lung diseases in Japanese. Sci Rep 2021;11:16250. [PMID: 34376770 DOI: 10.1038/s41598-021-95869-9] [Reference Citation Analysis]
6 O'Callaghan M, Bonella F, McCarthy C. Unclassifiable, or simply unclassified interstitial lung disease? Curr Opin Pulm Med 2021;27:405-13. [PMID: 34172623 DOI: 10.1097/MCP.0000000000000801] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Stainer A, Faverio P, Busnelli S, Catalano M, Della Zoppa M, Marruchella A, Pesci A, Luppi F. Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions. Int J Mol Sci 2021;22:6255. [PMID: 34200784 DOI: 10.3390/ijms22126255] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Shao T, Shi X, Yang S, Zhang W, Li X, Shu J, Alqalyoobi S, Zeki AA, Leung PS, Shuai Z. Interstitial Lung Disease in Connective Tissue Disease: A Common Lesion With Heterogeneous Mechanisms and Treatment Considerations. Front Immunol 2021;12:684699. [PMID: 34163483 DOI: 10.3389/fimmu.2021.684699] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
9 Yasutomo K. Genetics and animal models of familial pulmonary fibrosis. Int Immunol 2021:dxab026. [PMID: 34049386 DOI: 10.1093/intimm/dxab026] [Reference Citation Analysis]
10 Liu J, Deng Y, Wang Z, Mo B, Wei J, Cheng Z, Peng Q, Wei G, Li J, Shu Y, Yang H, Fang S, Luo G, Yang S, Wang Y, Zhu J, Yang J, Wu M, Xu X, Ge R, Zhang X, Xiong W, Wang X, Li Z. A nonsynonymous polymorphism (rs117179004, T392M) of hyaluronidase 1 (HYAL1) is associated with increased risk of idiopathic pulmonary fibrosis in Southern Han Chinese. J Clin Lab Anal 2021;35:e23782. [PMID: 33942374 DOI: 10.1002/jcla.23782] [Reference Citation Analysis]
11 Bonella F, Campo I, Zorzetto M, Boerner E, Ohshimo S, Theegarten D, Taube C, Costabel U. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF. Orphanet J Rare Dis 2021;16:111. [PMID: 33639995 DOI: 10.1186/s13023-021-01750-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Fang C, Huang H, Feng Y, Zhang Q, Wang N, Jing X, Guo J, Ferianc M, Xu Z. Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population. Sci Rep 2021;11:1443. [PMID: 33446833 DOI: 10.1038/s41598-020-80944-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Michalski JE, Schwartz DA. Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis. J Inflamm Res 2020;13:1305-18. [PMID: 33447070 DOI: 10.2147/JIR.S280958] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
14 Lou HQ, Huang CX, Li GY, Li P, Zhang SM, Li HG, Han L, Bao MH. The Association between MUC5B Rs35705950 and Risks of Idiopathic Interstitial Pneumonia, Systemic Sclerosis Interstitial Lung Disease, and Familial Interstitial Pneumonia: A Meta-Analysis. Iran J Public Health 2020;49:2240-50. [PMID: 34178730 DOI: 10.18502/ijph.v49i12.4801] [Reference Citation Analysis]
15 Utsunomiya A, Oyama N, Hasegawa M. Potential Biomarkers in Systemic Sclerosis: A Literature Review and Update. J Clin Med 2020;9:E3388. [PMID: 33105647 DOI: 10.3390/jcm9113388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
16 Shirai Y, Honda S, Ikari K, Kanai M, Takeda Y, Kamatani Y, Morisaki T, Tanaka E, Kumanogoh A, Harigai M, Okada Y. Association of the RPA3-UMAD1 locus with interstitial lung diseases complicated with rheumatoid arthritis in Japanese. Ann Rheum Dis 2020;79:1305-9. [PMID: 32737115 DOI: 10.1136/annrheumdis-2020-217256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Nishikiori H, Chiba H, Lee SH, Kondoh S, Kamo KI, Nakamura K, Ikeda K, Kuronuma K, Chung MP, Kondoh Y, Homma S, Inase N, Park MS, Takahashi H. A modified GAP model for East-Asian populations with idiopathic pulmonary fibrosis. Respir Investig 2020;58:395-402. [PMID: 32718834 DOI: 10.1016/j.resinv.2020.04.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
18 Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J. Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease. Am J Respir Crit Care Med 2020;201:650-60. [PMID: 31841044 DOI: 10.1164/rccm.201903-0563CI] [Cited by in Crossref: 28] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
19 Borie R, Kannengiesser C, Dupin C, Debray MP, Cazes A, Crestani B. Impact of genetic factors on fibrosing interstitial lung diseases. Incidence and clinical presentation in adults. Presse Med 2020;49:104024. [PMID: 32437840 DOI: 10.1016/j.lpm.2020.104024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
20 Wu EK, Ambrosini RD, Kottmann RM, Ritchlin CT, Schwarz EM, Rahimi H. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology. Curr Rheumatol Rev 2019;15:277-89. [PMID: 30652645 DOI: 10.2174/1573397115666190116102451] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
21 Shi X, Ma Y, Li H, Yu H. Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility. BMC Med Genet 2020;21:71. [PMID: 32252656 DOI: 10.1186/s12881-020-01005-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Moore C, Blumhagen RZ, Yang IV, Walts A, Powers J, Walker T, Bishop M, Russell P, Vestal B, Cardwell J, Markin CR, Mathai SK, Schwarz MI, Steele MP, Lee J, Brown KK, Loyd JE, Crapo JD, Silverman EK, Cho MH, James JA, Guthridge JM, Cogan JD, Kropski JA, Swigris JJ, Bair C, Kim DS, Ji W, Kim H, Song JW, Maier LA, Pacheco KA, Hirani N, Poon AS, Li F, Jenkins RG, Braybrooke R, Saini G, Maher TM, Molyneaux PL, Saunders P, Zhang Y, Gibson KF, Kass DJ, Rojas M, Sembrat J, Wolters PJ, Collard HR, Sundy JS, O'Riordan T, Strek ME, Noth I, Ma SF, Porteous MK, Kreider ME, Patel NB, Inoue Y, Hirose M, Arai T, Akagawa S, Eickelberg O, Fernandez IE, Behr J, Mogulkoc N, Corte TJ, Glaspole I, Tomassetti S, Ravaglia C, Poletti V, Crestani B, Borie R, Kannengiesser C, Parfrey H, Fiddler C, Rassl D, Molina-Molina M, Machahua C, Worboys AM, Gudmundsson G, Isaksson HJ, Lederer DJ, Podolanczuk AJ, Montesi SB, Bendstrup E, Danchel V, Selman M, Pardo A, Henry MT, Keane MP, Doran P, Vašáková M, Sterclova M, Ryerson CJ, Wilcox PG, Okamoto T, Furusawa H, Miyazaki Y, Laurent G, Baltic S, Prele C, Moodley Y, Shea BS, Ohta K, Suzukawa M, Narumoto O, Nathan SD, Venuto DC, Woldehanna ML, Kokturk N, de Andrade JA, Luckhardt T, Kulkarni T, Bonella F, Donnelly SC, McElroy A, Armstong ME, Aranda A, Carbone RG, Puppo F, Beckman KB, Nickerson DA, Fingerlin TE, Schwartz DA. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2019;200:199-208. [PMID: 31034279 DOI: 10.1164/rccm.201810-1891OC] [Cited by in Crossref: 37] [Cited by in F6Publishing: 48] [Article Influence: 18.5] [Reference Citation Analysis]
23 Hirano C, Ohshimo S, Horimasu Y, Iwamoto H, Fujitaka K, Hamada H, Kohno N, Komoto D, Awai K, Shime N, Bonella F, Guzman J, Kühl H, Costabel U, Hattori N. Baseline High-Resolution CT Findings Predict Acute Exacerbation of Idiopathic Pulmonary Fibrosis: German and Japanese Cohort Study. J Clin Med 2019;8:E2069. [PMID: 31771313 DOI: 10.3390/jcm8122069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
24 Schwartz DA. Idiopathic Pulmonary Fibrosis Is a Genetic Disease Involving Mucus and the Peripheral Airways. Ann Am Thorac Soc 2018;15:S192-7. [PMID: 30431344 DOI: 10.1513/AnnalsATS.201802-144AW] [Cited by in Crossref: 19] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
25 Borie R, Le Guen P, Ghanem M, Taillé C, Dupin C, Dieudé P, Kannengiesser C, Crestani B. The genetics of interstitial lung diseases. Eur Respir Rev 2019;28:190053. [PMID: 31554702 DOI: 10.1183/16000617.0053-2019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
26 Yanagihara T, Sato S, Upagupta C, Kolb M. What have we learned from basic science studies on idiopathic pulmonary fibrosis? Eur Respir Rev 2019;28:190029. [PMID: 31511255 DOI: 10.1183/16000617.0029-2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
27 Zhang Q, Wang Y, Qu D, Yu J, Yang J. The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B. Biomed Res Int 2019;2019:9712464. [PMID: 31309122 DOI: 10.1155/2019/9712464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
28 Mathai SK, Schwartz DA. Translational research in pulmonary fibrosis. Transl Res 2019;209:1-13. [PMID: 30768925 DOI: 10.1016/j.trsl.2019.02.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
29 Adegunsoye A, Vij R, Noth I. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. Chest 2019;155:1026-40. [PMID: 30660786 DOI: 10.1016/j.chest.2018.12.011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
30 Juge PA, Lee JS, Ebstein E, Furukawa H, Dobrinskikh E, Gazal S, Kannengiesser C, Ottaviani S, Oka S, Tohma S, Tsuchiya N, Rojas-Serrano J, González-Pérez MI, Mejía M, Buendía-Roldán I, Falfán-Valencia R, Ambrocio-Ortiz E, Manali E, Papiris SA, Karageorgas T, Boumpas D, Antoniou K, van Moorsel CHM, van der Vis J, de Man YA, Grutters JC, Wang Y, Borie R, Wemeau-Stervinou L, Wallaert B, Flipo RM, Nunes H, Valeyre D, Saidenberg-Kermanac'h N, Boissier MC, Marchand-Adam S, Frazier A, Richette P, Allanore Y, Sibilia J, Dromer C, Richez C, Schaeverbeke T, Lioté H, Thabut G, Nathan N, Amselem S, Soubrier M, Cottin V, Clément A, Deane K, Walts AD, Fingerlin T, Fischer A, Ryu JH, Matteson EL, Niewold TB, Assayag D, Gross A, Wolters P, Schwarz MI, Holers M, Solomon JJ, Doyle T, Rosas IO, Blauwendraat C, Nalls MA, Debray MP, Boileau C, Crestani B, Schwartz DA, Dieudé P. MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. N Engl J Med 2018;379:2209-19. [PMID: 30345907 DOI: 10.1056/NEJMoa1801562] [Cited by in Crossref: 144] [Cited by in F6Publishing: 161] [Article Influence: 36.0] [Reference Citation Analysis]
31 Wolters PJ, Blackwell TS, Eickelberg O, Loyd JE, Kaminski N, Jenkins G, Maher TM, Molina-Molina M, Noble PW, Raghu G, Richeldi L, Schwarz MI, Selman M, Wuyts WA, Schwartz DA. Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic? Lancet Respir Med 2018;6:154-60. [PMID: 29413083 DOI: 10.1016/S2213-2600(18)30007-9] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 17.8] [Reference Citation Analysis]
32 Saito S, Lasky JA, Hagiwara K, Kondoh Y. Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective. Respir Investig 2018;56:375-83. [PMID: 30061050 DOI: 10.1016/j.resinv.2018.06.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
33 Deng Y, Li Z, Liu J, Wang Z, Cao Y, Mou Y, Fu B, Mo B, Wei J, Cheng Z, Luo L, Li J, Shu Y, Wang X, Luo G, Yang S, Wang Y, Zhu J, Yang J, Wu M, Xu X, Ge R, Chen X, Peng Q, Wei G, Li Y, Yang H, Fang S, Zhang X, Xiong W. Targeted resequencing reveals genetic risks in patients with sporadic idiopathic pulmonary fibrosis. Hum Mutat 2018;39:1238-45. [PMID: 29920840 DOI: 10.1002/humu.23566] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
34 Hewlett JC, Kropski JA, Blackwell TS. Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets. Matrix Biol 2018;71-72:112-27. [PMID: 29625182 DOI: 10.1016/j.matbio.2018.03.021] [Cited by in Crossref: 52] [Cited by in F6Publishing: 78] [Article Influence: 13.0] [Reference Citation Analysis]
35 Yu G, Ibarra GH, Kaminski N. Fibrosis: Lessons from OMICS analyses of the human lung. Matrix Biol 2018;68-69:422-34. [PMID: 29567123 DOI: 10.1016/j.matbio.2018.03.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
36 Garcia CK. Insights from human genetic studies of lung and organ fibrosis. J Clin Invest 2018;128:36-44. [PMID: 29293091 DOI: 10.1172/JCI93556] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
37 Kropski JA, Young LR, Cogan JD, Mitchell DB, Lancaster LH, Worrell JA, Markin C, Liu N, Mason WR, Fingerlin TE, Schwartz DA, Lawson WE, Blackwell TS, Phillips JA 3rd, Loyd JE. Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med 2017;195:1423-8. [PMID: 27786550 DOI: 10.1164/rccm.201609-1820PP] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
38 Tepede A, Yogaratnam D. Nintedanib for Idiopathic Pulmonary Fibrosis. Journal of Pharmacy Practice 2019;32:199-206. [DOI: 10.1177/0897190017735242] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
39 Kaur A, Mathai SK, Schwartz DA. Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment. Front Med (Lausanne) 2017;4:154. [PMID: 28993806 DOI: 10.3389/fmed.2017.00154] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
40 Horimasu Y, Ishikawa N, Taniwaki M, Yamaguchi K, Hamai K, Iwamoto H, Ohshimo S, Hamada H, Hattori N, Okada M, Arihiro K, Ohtsuki Y, Kohno N. Gene expression profiling of idiopathic interstitial pneumonias (IIPs): identification of potential diagnostic markers and therapeutic targets. BMC Med Genet 2017;18:88. [PMID: 28821283 DOI: 10.1186/s12881-017-0449-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
41 Helling BA, Gerber AN, Kadiyala V, Sasse SK, Pedersen BS, Sparks L, Nakano Y, Okamoto T, Evans CM, Yang IV, Schwartz DA. Regulation of MUC5B Expression in Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol 2017;57:91-9. [PMID: 28272906 DOI: 10.1165/rcmb.2017-0046OC] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 8.6] [Reference Citation Analysis]
42 Evans CM, Fingerlin TE, Schwarz MI, Lynch D, Kurche J, Warg L, Yang IV, Schwartz DA. Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways. Physiol Rev 2016;96:1567-91. [PMID: 27630174 DOI: 10.1152/physrev.00004.2016] [Cited by in Crossref: 108] [Cited by in F6Publishing: 119] [Article Influence: 21.6] [Reference Citation Analysis]
43 Borie R, Kannengiesser C, Sicre de Fontbrune F, Gouya L, Nathan N, Crestani B. Management of suspected monogenic lung fibrosis in a specialised centre. Eur Respir Rev 2017;26:160122. [DOI: 10.1183/16000617.0122-2016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
44 Horimasu Y, Ishikawa N, Tanaka S, Hirano C, Iwamoto H, Ohshimo S, Fujitaka K, Hamada H, Hattori N, Kohno N. MUC1 in lung adenocarcinoma: cross-sectional genetic and serological study. BMC Cancer 2017;17:263. [PMID: 28403862 DOI: 10.1186/s12885-017-3272-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
45 Jo HE, Corte TJ. Nintedanib for idiopathic pulmonary fibrosis in the Japanese population. Respirology 2017;22:630-1. [PMID: 28370834 DOI: 10.1111/resp.13033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
46 Yang J, Xu T, Gomez DR, Jeter M, Levy LB, Song Y, Hahn S, Liao Z, Yuan X. The Pulmonary Fibrosis Associated MUC5B Promoter Polymorphism Is Prognostic of the Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC) Receiving Definitive Radiotherapy. Transl Oncol 2017;10:197-202. [PMID: 28189065 DOI: 10.1016/j.tranon.2016.12.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
47 Spagnolo P, Cottin V. Genetics of idiopathic pulmonary fibrosis: from mechanistic pathways to personalised medicine. J Med Genet 2017;54:93-9. [DOI: 10.1136/jmedgenet-2016-103973] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
48 Borie R, Tabèze L, Thabut G, Nunes H, Cottin V, Marchand-Adam S, Prevot G, Tazi A, Cadranel J, Mal H, Wemeau-Stervinou L, Bergeron Lafaurie A, Israel-Biet D, Picard C, Reynaud Gaubert M, Jouneau S, Naccache JM, Mankikian J, Ménard C, Cordier JF, Valeyre D, Reocreux M, Grandchamp B, Revy P, Kannengiesser C, Crestani B. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis. Eur Respir J 2016;48:1721-31. [PMID: 27836952 DOI: 10.1183/13993003.02115-2015] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 12.2] [Reference Citation Analysis]
49 Mathai SK, Newton CA, Schwartz DA, Garcia CK. Pulmonary fibrosis in the era of stratified medicine. Thorax 2016;71:1154-60. [PMID: 27799632 DOI: 10.1136/thoraxjnl-2016-209172] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 5.5] [Reference Citation Analysis]
50 Yang IV, Fingerlin TE, Evans CM, Schwarz MI, Schwartz DA. MUC5B and Idiopathic Pulmonary Fibrosis. Ann Am Thorac Soc 2015;12 Suppl 2:S193-9. [PMID: 26595739 DOI: 10.1513/AnnalsATS.201503-110AW] [Cited by in F6Publishing: 22] [Reference Citation Analysis]
51 Conti C, Montero-Fernandez A, Borg E, Osadolor T, Viola P, De Lauretis A, Stock CJ, Bonifazi M, Bonini M, Caramori G, Lindahl G, Blasi FB, Nicholson AG, Wells AU, Sestini P, Renzoni E. Mucins MUC5B and MUC5AC in Distal Airways and Honeycomb Spaces: Comparison among Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia, Fibrotic Nonspecific Interstitial Pneumonitis, and Control Lungs. Am J Respir Crit Care Med 2016;193:462-4. [PMID: 26871672 DOI: 10.1164/rccm.201507-1322LE] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
52 Fingerlin TE, Zhang W, Yang IV, Ainsworth HC, Russell PH, Blumhagen RZ, Schwarz MI, Brown KK, Steele MP, Loyd JE, Cosgrove GP, Lynch DA, Groshong S, Collard HR, Wolters PJ, Bradford WZ, Kossen K, Seiwert SD, du Bois RM, Garcia CK, Devine MS, Gudmundsson G, Isaksson HJ, Kaminski N, Zhang Y, Gibson KF, Lancaster LH, Maher TM, Molyneaux PL, Wells AU, Moffatt MF, Selman M, Pardo A, Kim DS, Crapo JD, Make BJ, Regan EA, Walek DS, Daniel JJ, Kamatani Y, Zelenika D, Murphy E, Smith K, McKean D, Pedersen BS, Talbert J, Powers J, Markin CR, Beckman KB, Lathrop M, Freed B, Langefeld CD, Schwartz DA. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. BMC Genet 2016;17:74. [PMID: 27266705 DOI: 10.1186/s12863-016-0377-2] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
53 Chung JH, Lynch DA. The Value of a Multidisciplinary Approach to the Diagnosis of Usual Interstitial Pneumonitis and Idiopathic Pulmonary Fibrosis: Radiology, Pathology, and Clinical Correlation. AJR Am J Roentgenol 2016;206:463-71. [PMID: 26901003 DOI: 10.2214/AJR.15.15627] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
54 Mathai SK, Schwartz DA. Taking the "I" out of IPF. Eur Respir J 2015;45:1539-41. [PMID: 26028619 DOI: 10.1183/09031936.00052715] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
55 Kondoh S, Chiba H, Nishikiori H, Umeda Y, Kuronuma K, Otsuka M, Yamada G, Ohnishi H, Mori M, Kondoh Y, Taniguchi H, Homma S, Takahashi H. Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis. Respir Investig 2016;54:327-33. [PMID: 27566380 DOI: 10.1016/j.resinv.2016.02.009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
56 Jo HE, Corte TJ, Wort SJ, Eves ND, Piper A, Wainwright C. Year in review 2015: Interstitial lung disease, pulmonary vascular disease, pulmonary function, sleep and ventilation, cystic fibrosis and paediatric lung disease: Year in review 2015. Respirology 2016;21:556-66. [DOI: 10.1111/resp.12749] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
57 Zhu QQ, Zhang XL, Zhang SM, Tang SW, Min HY, Yi L, Xu B, Song Y. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations. Medicine (Baltimore) 2015;94:e1901. [PMID: 26512610 DOI: 10.1097/MD.0000000000001901] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
58 Chung JH, Peljto AL, Chawla A, Talbert JL, McKean DF, Rho BH, Fingerlin TE, Schwarz MI, Schwartz DA, Lynch DA. CT Imaging Phenotypes of Pulmonary Fibrosis in the MUC5B Promoter Site Polymorphism. Chest 2016;149:1215-22. [PMID: 26836909 DOI: 10.1016/j.chest.2015.11.009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
59 van der Vis JJ, Snetselaar R, Kazemier KM, ten Klooster L, Grutters JC, van Moorsel CH. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias. Respirology 2016;21:712-7. [PMID: 26699835 DOI: 10.1111/resp.12728] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
60 Garner J, George PM, Renzoni E. Cough in interstitial lung disease. Pulmonary Pharmacology & Therapeutics 2015;35:122-8. [DOI: 10.1016/j.pupt.2015.10.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
61 van Moorsel CH, Hoffman TW, van Batenburg AA, Klay D, van der Vis JJ, Grutters JC. Understanding Idiopathic Interstitial Pneumonia: A Gene-Based Review of Stressed Lungs. Biomed Res Int 2015;2015:304186. [PMID: 26539479 DOI: 10.1155/2015/304186] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
62 Mathai SK, Yang IV, Schwarz MI, Schwartz DA. Incorporating genetics into the identification and treatment of Idiopathic Pulmonary Fibrosis. BMC Med 2015;13:191. [PMID: 26400796 DOI: 10.1186/s12916-015-0434-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
63 Kishore A, Žižková V, Kocourková L, Petřek M. A Dataset of 26 Candidate Gene and Pro-Inflammatory Cytokine Variants for Association Studies in Idiopathic Pulmonary Fibrosis: Frequency Distribution in Normal Czech Population. Front Immunol 2015;6:476. [PMID: 26441981 DOI: 10.3389/fimmu.2015.00476] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
64 Lee MG, Lee YH. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis. Inflamm Res 2015;64:463-70. [PMID: 25926289 DOI: 10.1007/s00011-015-0829-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
65 Furukawa H, Oka S, Shimada K, Tsuchiya N, Tohma S. Genetics of Interstitial Lung Disease: Vol de Nuit (Night Flight). Clin Med Insights Circ Respir Pulm Med 2015;9:1-7. [PMID: 26056507 DOI: 10.4137/CCRPM.S23283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 0.3] [Reference Citation Analysis]
66 Kropski JA, Blackwell TS, Loyd JE. The genetic basis of idiopathic pulmonary fibrosis. Eur Respir J 2015;45:1717-27. [PMID: 25837031 DOI: 10.1183/09031936.00163814] [Cited by in Crossref: 95] [Cited by in F6Publishing: 95] [Article Influence: 13.6] [Reference Citation Analysis]